Skip to content

Lifecore Biomedical, Inc. LFCR Accrued Liabilities, Current

Accrued Liabilities, Current at other companies

Baxter International logo
Baxter InternationalBAX
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
Biodesix, Inc. logo
Biodesix, Inc.BDSX
Charles River Laboratories logo
Charles River LaboratoriesCRL
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
Labcorp Holdings logo
Labcorp HoldingsLH

Other financials

Income statement

See full
Revenue$23.2M-36.4%
Gross profit$4.5M-68.1%
Operating income-$4.7M
Net income-$15.0M-1,206%
EPS (diluted)-$0.43-1,333%

Balance sheet

See full
Cash & equivalents$20.8M+152%
Total debt$156.9M+1,310%
Total equity-$28.4M-2,229%
Total assets$225.5M-5.8%

Cash flow

See full
Operating cash flow$4.7M
CapEx$1.1M-46.7%
Free cash flow$3.6M

Valuation

See full
Market cap$196.92M-37.3%
Enterprise value$333.06M+6.3%
P/S1.6×+0.5×

Profitability

See full
Gross margin31.3%-1.4pp
Operating margin-14.5%-2.2pp
Net margin-30%
FCF margin-36.4%

Returns & leverage

See full
Return on equity-612.1%
Debt / equity8.3×-1.5×
Current ratio3.8×+0.9×

Where this comes from

Reported directly by Lifecore Biomedical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s accrued liabilities, current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s accrued liabilities, current?
Lifecore Biomedical, Inc. (LFCR) reported accrued liabilities, current of $13.48M in Q1 2026.
How has Lifecore Biomedical, Inc.'s accrued liabilities, current changed year-over-year?
Lifecore Biomedical, Inc.'s accrued liabilities, current decreased by 38.6% year-over-year, from $21.96M to $13.48M.
What is the long-term trend for Lifecore Biomedical, Inc.'s accrued liabilities, current?
Over 2 years (2024 to 2026), Lifecore Biomedical, Inc.'s accrued liabilities, current has grown at a -22.7% compound annual growth rate (CAGR), from $22.54M to $13.48M.